GlaxoSmithKline to buy sports nutrition company

Pharmaceuticals giant GlaxoSmithKline unveiled a deal today to buy the company behind Maximuscle protein shakes used by rugby player Gavin Henson, cricket star Stuart Broad and footballer Jermaine Jenas.

GlaxoSmithKline to buy sports nutrition company

Pharmaceuticals giant GlaxoSmithKline unveiled a deal today to buy the company behind Maximuscle protein shakes used by rugby player Gavin Henson, cricket star Stuart Broad and footballer Jermaine Jenas.

Britain’s biggest drugmaker bought Maxinutrition Group Holdings, Europe’s top-selling sports nutrition company, from Darwin Private Equity for £162m (€192m).

The muscle building powders will beef up Glaxo’s growing portfolio of brands that includes Ribena, Sensodyne toothpaste and Lucozade.

Maxinutrition, which also owns Maxifuel dietary supplements and Maxitone muscle toning supplements for women, has increased its sales by 21% over the last three years to £36m (€42.6m) in the year to April 2010.

John Clarke, Glaxo’s president of consumer healthcare, said, “This deal will give (Glaxo) a strong presence in the fast developing protein-based sports nutrition market, appealing across a broad spectrum of consumers from elite athletes to sports participants and those seeking additional nutritional supplementation.”

The brands are currently sold in Europe but Glaxo will market them around the world, added Mr Clarke.

Peter Boddy, chief executive of Hemel Hempstead-based Maxinutrition, said: “Maxinutrition is a fast growing, focused sports nutrition business with excellent growth prospects and a strong management team – it’s a natural fit for (Glaxo) and its ambition to extend and expand its nutritional healthcare business.”

Last month the Brentford-based company announced it would create about 1,000 jobs and invest £500m (€592m) in manufacturing following tax reforms announced by the UK government.

It said a planned 10% reduction in corporation tax on profits generated from UK-owned intellectual property would allow the firm to develop new technology, build new facilities and invest in fledgling companies.

Glaxo has research bases at Stevenage and Ware in Hertfordshire and Harlow in Essex.

Its UK manufacturing operations include sites at Ulverston in Cumbria, Montrose, Angus, and Irvine in Ayrshire.

More in this section

Lunchtime
News Wrap

A lunchtime summary of content highlights on the Irish Examiner website. Delivered at 1pm each day.

Sign up
Revoiced
Newsletter

Our Covid-free newsletter brings together some of the best bits from irishexaminer.com, as chosen by our editor, direct to your inbox every Monday.

Sign up